Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations
出版年份 2021 全文链接
标题
Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations
作者
关键词
-
出版物
Scientific Reports
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-22
DOI
10.1038/s41598-021-94212-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome
- (2021) Lyndsey L. Anderson et al. ACS Chemical Neuroscience
- Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
- (2021) Francesco Paolo Busardò et al. Pharmaceuticals
- Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
- (2021) Jackson M. J. Oultram et al. Biomedicines
- Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization
- (2021) Peter T. Doohan et al. AAPS Journal
- Interactions between cannabidiol and Δ 9 ‐tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome
- (2020) Lyndsey L. Anderson et al. BRITISH JOURNAL OF PHARMACOLOGY
- (‒)-Cannabidiolic Acid, a Still Overlooked Bioactive Compound: An Introductory Review and Preliminary Research
- (2020) Marialuisa Formato et al. MOLECULES
- Digoxin: Pharmacology and toxicology—A review
- (2020) Jiri Patocka et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
- (2020) Joseph J. Wakshlag et al. Frontiers in Veterinary Science
- Long-term safety and efficacy of cannabidiol in children and adults with treatment-resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results
- (2019) Linda C. Laux et al. EPILEPSY RESEARCH
- Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol
- (2019) Samuel D. Banister et al. ACS Chemical Neuroscience
- Natural products as multidrug resistance modulators in cancer
- (2019) Amit Kumar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome
- (2019) Lyndsey L. Anderson et al. JOURNAL OF NATURAL PRODUCTS
- Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
- (2018) Sandra Blasco-Benito et al. BIOCHEMICAL PHARMACOLOGY
- Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study
- (2018) Lanfranco Pellesi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- New insights in the in vitro characterisation and molecular modelling of the P-glycoprotein inhibitory promiscuity
- (2018) Giovanni Bocci et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Inhibition of P-Glycoprotein Mediated Efflux in Caco-2 Cells by Phytic Acid
- (2018) Lujia Li et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Role of P -glycoprotein in deoxynivalenol-mediated in vitro toxicity
- (2018) Lada Ivanova et al. TOXICOLOGY LETTERS
- Nonionic surfactants increase digoxin absorption in Caco-2 and MDCKII MDR1 cells: Impact on P-glycoprotein inhibition, barrier function, and repeated cellular exposure
- (2018) Ahmed A. Abdulhussein Al-Ali et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain
- (2018) Erin M. Rock et al. PSYCHOPHARMACOLOGY
- Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
- (2018) A. Suraev et al. Scientific Reports
- Cannabis constituent synergy in a mouse neuropathic pain model
- (2017) Sherelle L. Casey et al. PAIN
- Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats
- (2017) Erin M. Rock et al. PSYCHOPHARMACOLOGY
- Screening of conventional anticonvulsants in a genetic mouse model of epilepsy
- (2017) Nicole A. Hawkins et al. Annals of Clinical and Translational Neurology
- Cannabinoids and Cytochrome P450 Interactions
- (2016) Ondřej Zendulka et al. CURRENT DRUG METABOLISM
- ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice
- (2016) Natalia Brzozowska et al. PeerJ
- Evaluation of P-Glycoprotein Inhibitory Potential Using a Rhodamine 123 Accumulation Assay
- (2016) Elodie Jouan et al. Pharmaceutics
- The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation
- (2016) S M D K Ganga Senarathna et al. PLoS One
- Effects of Cremophor EL on the absorption of orally administered saquinavir and fexofenadine in healthy subjects
- (2015) Atsuko Tomaru et al. Drug Metabolism and Pharmacokinetics
- Effect of combined doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping
- (2015) Erin M. Rock et al. PSYCHOPHARMACOLOGY
- Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study
- (2013) Valeria Feinshtein et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance
- (2013) Ankit Saneja et al. Expert Opinion on Drug Delivery
- Cannabidiolic acid prevents vomiting inSuncus murinusand nausea-induced behaviour in rats by enhancing 5-HT1Areceptor activation
- (2012) D Bolognini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Enhanced Brain Disposition and Effects of Δ9-Tetrahydrocannabinol in P-Glycoprotein and Breast Cancer Resistance Protein Knockout Mice
- (2012) Adena S. Spiro et al. PLoS One
- Substrate- and Species-dependent Inhibition of P-glycoprotein-mediated Transport: Implications for Predicting in vivo Drug Interactions
- (2011) Joseph K. Zolnerciks et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol☆
- (2010) Gerald T. DeLong et al. DRUG AND ALCOHOL DEPENDENCE
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Substrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay Design
- (2008) N. Giri et al. DRUG METABOLISM AND DISPOSITION
- Characterization of Substrates and Inhibitors for the In Vitro Assessment of Bcrp Mediated Drug–Drug Interactions
- (2008) Uwe Muenster et al. PHARMACEUTICAL RESEARCH
- The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids
- (2007) M L Holland et al. BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started